Patient LEVEL Cost Analysis of Mechanical Thrombectomy and Intravenous Thrombolysis for the Treatment of ACUTE Ischemic Stroke Patients in Hungary

Author(s)

Langer A1, Jozifek E2, Kónyi A2, Herczeg Z2, Némethné G2, Kovács S3, Zemplényi A4
1University of Pécs, Pécs, BA, Hungary, 2University of Pécs, Pécs, Hungary, 3University of Pécs, Centre for Health Technology Assessment, Pécs, Hungary, 41) University of Pécs Faculty of Pharmacy, Divison of Pharmacoeconomics, 2) Centre for Health Technology Assessment, Pécs, BA, Hungary

OBJECTIVES : Intravenous thrombolysis (IVT) with alteplase and mechanical thrombectomy (MT) are widely used in Hungary in the management of acute ischemic stroke (AIS), however, there is a lack of data on the actual cost of these procedures. Our aim is to assess the cost of AIS cases from provider’s perspective.

METHODS : Using the Stroke Registry of University of Pécs we included AIS patients registered between 2018 January and 2019 June treated with IVT or MT or both. We retrieved data from the electronic medical record on resource utilization such as length of stay (LOS) from every department they have visited during their stroke treatment. We have collected patient level data on the cost of laboratory, radiological and other diagnostical procedures. Unit costs were provided by the accounting department regarding cost of one patient day (including nursing, doctors’ salary, equipment, drugs, and capital cost), and cost of MT. We assigned costs to patients individually to determine the patient level cost of care.

RESULTS : We have identified 194 AIS patients, 113 only IVT, 49 only MT, and 32 IVT+MT. Average cost of IVT with alteplase was 552±110 €. Average cost of MT surgery was 4094±1712 €. Average LOS was 6.6±6.3, 10.5±12.2, 8.7±6.2 days; average cost of hospitalization was 1575±1872, 2392±2501, 2062±1348 €; average cost of diagnostic procedures was 252±144, 290±98, 325±92 €; total cost of care was 2390±1992, 6781±3042, 6984±1798 € for IVT, MT and IVT+MT patient groups respectively.

CONCLUSIONS : Both MT itself and MT combined with IVT are very expensive procedures. Due to the increasing number of patients treated with MT, it is important to assess the cost-effectiveness of this technique in the local population to evaluate value for money. Our data and cost collecting methods make further cost-effectiveness studies possible.

Conference/Value in Health Info

2020-11, ISPOR Europe 2020, Milan, Italy

Value in Health, Volume 23, Issue S2 (December 2020)

Code

PCV29

Topic

Economic Evaluation

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×